(R)-1-(5,8-Dihydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-4-methylpent-3-en-1-yl (Z)-4-oxo-4-(p-tolyl)but-2-enoate

ID: ALA4557993

PubChem CID: 155554594

Max Phase: Preclinical

Molecular Formula: C27H24O7

Molecular Weight: 460.48

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)=CC[C@@H](OC(=O)/C=C\C(=O)c1ccc(C)cc1)C1=CC(=O)c2c(O)ccc(O)c2C1=O

Standard InChI:  InChI=1S/C27H24O7/c1-15(2)4-12-23(34-24(32)13-11-19(28)17-7-5-16(3)6-8-17)18-14-22(31)25-20(29)9-10-21(30)26(25)27(18)33/h4-11,13-14,23,29-30H,12H2,1-3H3/b13-11-/t23-/m1/s1

Standard InChI Key:  QYCGSVUGPNGYQQ-GQZPPLQUSA-N

Molfile:  

 
     RDKit          2D

 34 36  0  0  0  0  0  0  0  0999 V2000
   13.7629   -6.0422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7617   -6.8618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4698   -7.2707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4680   -5.6334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1766   -6.0386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1774   -6.8576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8859   -7.2647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5942   -6.8539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5894   -6.0318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8803   -5.6284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8760   -4.8112    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.8876   -8.0819    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.2947   -5.6189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0048   -6.0231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7100   -5.6102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4202   -6.0145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4252   -6.8317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1254   -5.6016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2897   -4.8017    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.9949   -4.3888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9899   -3.5716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7051   -4.7931    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.6951   -3.1587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4656   -4.8162    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4717   -8.0879    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.4053   -3.5630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1105   -3.1501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4103   -4.3802    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.8181   -3.5591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5228   -3.1469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5182   -2.3288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8031   -1.9247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1013   -2.3393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2229   -1.9150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  5  1  0
 10 11  2  0
  7 12  2  0
  9 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 13 19  1  6
 19 20  1  0
 20 21  1  0
 20 22  2  0
 21 23  2  0
  4 24  1  0
  3 25  1  0
 23 26  1  0
 26 27  1  0
 26 28  2  0
 27 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 27  1  0
 31 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4557993

    ---

Associated Targets(Human)

L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 460.48Molecular Weight (Monoisotopic): 460.1522AlogP: 4.42#Rotatable Bonds: 7
Polar Surface Area: 117.97Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.50CX Basic pKa: CX LogP: 6.14CX LogD: 6.10
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.21Np Likeness Score: 1.45

References

1. Sun WX, Han HW, Yang MK, Wen ZL, Wang YS, Fu JY, Lu YT, Wang MY, Bao JX, Lu GH, Qi JL, Wang XM, Lin HY, Yang YH..  (2019)  Design, synthesis and biological evaluation of benzoylacrylic acid shikonin ester derivatives as irreversible dual inhibitors of tubulin and EGFR.,  27  (23): [PMID:31648877] [10.1016/j.bmc.2019.115153]

Source